Oscar Health (NYSE:OSCR) Releases Earnings Results, Beats Estimates By $0.96 EPS

Key Points

• Oscar reported Q1 EPS of $2.07, beating estimates by $0.96, with revenue of $4.65B (+52.6% YoY) and membership accelerating to 3.2 million, alongside strong operating income and adjusted EBITDA.
• Management reaffirmed full‑year 2026 guidance but cautioned that elevated risk adjustment (~24%) and market morbidity uncertainty could materially affect 2026 EBITDA; the company entered the quarter with a strong liquidity cushion of $8.1B in cash & investments and ~$1.7B statutory surplus.
• CEO Mark T. Bertolini bought 1,000,000 shares at $11.92, increasing insider ownership (now 25.11%), and the stock jumped to about $19.92 on the print while analysts maintain a consensus "Hold" with a $16.78 target.

Oscar Health (NYSE:OSCR - Get Free Report) released its quarterly earnings results on Wednesday. The company reported $2.07 EPS for the quarter, beating the consensus estimate of $1.11 by $0.96, FiscalAI reports. Oscar Health had a negative net margin of 3.79% and a negative return on equity of 39.35%. The firm had revenue of $4.65 billion during the quarter, compared to the consensus estimate of $4.90 billion. During the same quarter in the prior year, the firm earned $0.92 EPS. Oscar Health's revenue for the quarter was up 52.6% on a year-over-year basis.

Here are the key takeaways from Oscar Health's conference call:

• Oscar reported a strong Q1 with $4.6B revenue (+53% YoY), earnings from operations of $704M, net income of $679M and adjusted EBITDA of $727M, and management reaffirmed full‑year 2026 guidance.
• Membership accelerated to 3.2 million (56% YoY), driven by above‑market open enrollment growth and solid retention, supporting scale and revenue upside.
• SG&A efficiency improved to a company‑low 15.2% of revenue, credited to disciplined cost management and expanding AI/tech use cases that management says will further lower per‑member costs.
• Risk adjustment remains a key swing factor: Q1 RA ran ~24% (seasonal/claims dynamics), above the company’s full‑year target of ~20%, and management cautioned RA and market morbidity uncertainty could materially affect 2026 EBITDA until further Wakely/claims data arrive.
• Balance sheet and capital position are strong with $8.1B cash & investments and ~$1.7B statutory surplus (including ~$809M excess), giving flexibility to fund growth and absorb volatility.

Oscar Health Stock Performance

Shares of Oscar Health stock traded up $1.98 on Wednesday, reaching $19.92. 18,840,597 shares of the stock were exchanged, compared to its average volume of 7,699,831. The firm has a market capitalization of $5.93 billion, a PE ratio of -11.45 and a beta of 2.34. Oscar Health has a 1-year low of $10.69 and a 1-year high of $23.80. The business has a fifty day moving average price of $14.11 and a two-hundred day moving average price of $15.28. The company has a current ratio of 0.96, a quick ratio of 0.96 and a debt-to-equity ratio of 0.44.

Insiders Place Their Bets

In other Oscar Health news, CEO Mark T. Bertolini acquired 1,000,000 shares of the stock in a transaction on Monday, April 6th. The shares were bought at an average price of $11.92 per share, with a total value of $11,920,000.00. Following the acquisition, the chief executive officer owned 10,196,876 shares of the company's stock, valued at $121,546,761.92. This trade represents a 10.87% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 25.11% of the company's stock.

Institutional Trading of Oscar Health

Hedge funds have recently modified their holdings of the business. Focus Partners Wealth grew its holdings in Oscar Health by 1.4% during the third quarter. Focus Partners Wealth now owns 57,787 shares of the company's stock worth $1,094,000 after acquiring an additional 824 shares during the period. Equitable Holdings Inc. lifted its holdings in Oscar Health by 7.0% in the fourth quarter. Equitable Holdings Inc. now owns 12,975 shares of the company's stock valued at $186,000 after acquiring an additional 850 shares during the period. Captrust Financial Advisors boosted its position in shares of Oscar Health by 2.0% during the 4th quarter. Captrust Financial Advisors now owns 45,754 shares of the company's stock worth $657,000 after purchasing an additional 895 shares in the last quarter. O Shaughnessy Asset Management LLC boosted its position in shares of Oscar Health by 5.6% during the 4th quarter. O Shaughnessy Asset Management LLC now owns 17,774 shares of the company's stock worth $255,000 after purchasing an additional 938 shares in the last quarter. Finally, Binnacle Investments Inc grew its stake in shares of Oscar Health by 28.6% during the 3rd quarter. Binnacle Investments Inc now owns 4,500 shares of the company's stock worth $85,000 after purchasing an additional 1,000 shares during the period. 75.70% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on OSCR shares. Jefferies Financial Group upgraded shares of Oscar Health from an "underperform" rating to a "hold" rating and lifted their price objective for the company from $10.00 to $16.00 in a research note on Monday, April 20th. Wolfe Research began coverage on Oscar Health in a report on Tuesday. They set a "peer perform" rating on the stock. UBS Group reaffirmed a "neutral" rating and set a $15.00 price objective on shares of Oscar Health in a research note on Wednesday, February 11th. Raymond James Financial upgraded Oscar Health from a "market perform" rating to an "outperform" rating and set a $18.00 target price on the stock in a research note on Thursday, February 12th. Finally, Weiss Ratings restated a "sell (d)" rating on shares of Oscar Health in a research note on Tuesday, April 21st. Two equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus price target of $16.78.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company's primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.